Emergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings Results
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 5 August 2026
What it is about
Paul Anthony WilliamsCharles Schwab Investment Management IncDevelopment AuthoritySecurities Exchange CommissionDimensional Fund AdvisorsConnor Clark Lunn Investment Management LtdBiomedical Advanced ResearchMillennium Management
Who published it, and when
How it spread - 1 original report
Wed, 5 August 2026
1 report- dailypolitical.com20:10first to report
Emergent Biosolutions (NYSE:EBS – Get Free Report) posted its quarterly earnings data on Wednesday. The biopharmaceutical company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.68, FiscalAI reports. The business had revenue of $234.30 million for the quarter, compared to analysts’ expectations of $177.50 million. Emergent Biosolutions […]